
EmerVax to Make Debut Presentation at RNA Leaders Europe Congress 2025 in Basel Switzerland
Unveiling the Future of Circular RNA Vaccines with emxRNA™ Technology HOUSTON, TX, UNITED STATES, February 28, 2025 /EINPresswire.com/ -- EmerVax, a pioneering developer of a proprietary circular RNA-based vaccine platform (emxRNA™), is set to present …